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Abstract 
A few randomised controlled trials (RCTs) show that Acceptance and Commitment 
Therapy (ACT) is beneficial for people with Multiple Sclerosis (MS), but the 
effectiveness of telephone-supported self-help ACT for people with MS with low 
mood has not been evaluated. We assessed the feasibility of conducting an RCT of 
an intervention (8 weekly telephone-calls plus a self-help ACT book) compared to 
treatment-as-usual. Participants’ mood, quality of life, and impact of MS were 
assessed at baseline and 12 weeks post-randomisation. Some were interviewed to 
assess feasibility and acceptability. Twenty-seven participants were randomised. 
Most participants found the trial procedures acceptable. We found a large and 
significant effect at follow-up, favouring the intervention in reducing anxiety (d=0.84, 
95% CI=0.02-1.66). However, the high attrition rate (33% overall) meant that the trial 
in its current format was not feasible. The intervention needs to be revised following 
user-testing and feedback before it can be put to a full trial. 
Keywords: Acceptance and Commitment Therapy, Multiple Sclerosis, Teletherapy, 
Bibliotherapy, Randomised Controlled Trial, Guided Self-help 
 
Introduction 
Multiple Sclerosis (MS) is a central nervous system disease, wherein brain-areas are 
inflamed or destroyed by the immune system. More than 100,000 people in the UK 
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are currently diagnosed with MS (MS Trust, 2017): most have a relapsing-remitting 
form; some stay as relapsing-remitting and a minority remain benign, however, for 
most, symptoms become permanent and degenerative (termed progressive MS).  
MS can have diverse and unpredictable effects on psychological wellbeing 
(Wilkinson & das Nair, 2013) reflected in high prevalence-estimates for depression 
(30%)  and anxiety (22%) (Boeschoten et al., 2017). Psychological and psychosocial 
problems frequently arise in relation to physical functioning, fatigue, pain, cognition, 
and relationships with others (Khan, Turner‐Stokes, Ng, Kilpatrick, & Amatya, 2007). 
Acceptance and Commitment Therapy (ACT) 
ACT is a third-wave of Cognitive-Behavioural Therapy (CBT) underpinned by the 
theory of psychological flexibility, and is efficacious across a broad range of physical 
and psychological symptoms (A-tjak et al., 2015; Ruiz, 2010; Hacker, Stone, & 
MacBeth, 2016). ACT is designed to improve functioning and quality of life (QoL) by 
enabling individuals to live in accordance with personally-held values (Hayes, 
Strosahl, & Wilson, 1999). The model views experiential avoidance as a core 
pathogenic process, and attempts to increase acceptance of aversive experiences: 
as a means of promoting engagement with valued, and previously avoided, activities 
(Dahl, Wilson, & Nilsson, 2004).  
ACT may be particularly suited to those with chronic physical health conditions, as 
traditional CBT thought-challenging of illness-beliefs may be limited when such 
cognitions could be accurate (Dennison, Moss-Morris, & Chalder, 2009). 
Furthermore, there is evidence that, in MS, avoidant coping strategies predict poor 
outcomes (Pakenham, 1999), and acceptance is the strongest predictor of 
adjustment (Pakenham, 2006). There is some preliminary research to suggest that 
group-based face-to-face ACT can be effective in reducing experiential avoidance 
and psychological distress in people with MS (Nordin & Rorsman, 2012; Pakenham, 
Mawdsley, Brown, & Burton, 2017).  
Teletherapy 
ACT is typically delivered face-to-face, but other delivery-formats warrant evaluation 
due to the costs of providing face-to-face therapy and because of a lack of services, 
particularly for those living in remote areas. Furthermore, people with MS may not be 
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able to access face-to-face therapies due to MS-related fatigue and reduced 
mobility. Telephone-psychotherapy (teletherapy) facilitates delivery to people in their 
own home: a recent review found that the teletherapy format could be efficacious for 
improving psychological outcomes (including depression, fatigue, and quality of life) 
in people with MS (Proctor, Moghaddam, Vogt, & das Nair, 2018); however, many of 
the studies were of poor methodological quality, so findings should be interpreted 
with caution. 
Bibliotherapy 
Bibliotherapy (self-help texts) is another common alternative or adjunct to face-to-
face therapy, which can be supplemented with teletherapy. Meta-analyses have 
shown that bibliotherapies – including ACT-based bibliotherapies – can improve 
psychological outcomes, as compared to control conditions (den Boer, Wiersma, & 
van den Bosch, 2004; French, Golijani-Moghaddam & Schröder, 2017). A previous 
trial of an eight-week telephone-supported CBT bibliotherapy for people with MS 
found significant reductions in depression (Mohr et al., 2000). However, the trial was 
specific to those with depression diagnoses and did not consider the multitude of 
other psychological difficulties experienced by people with MS.  
A telephone-supported ACT bibliotherapy may therefore provide an appropriate, 
accessible, and effective way of delivering psychotherapy to people with MS and 
psychological distress. To date, no studies have examined whether this format of 
ACT intervention is feasible within this population.  
Aims 
The primary aim of this study was to explore the feasibility of conducting an RCT of 
telephone-supported ACT bibliotherapy plus treatment-as-usual (TAU), compared 
with a TAU control group, for people with MS and psychological distress. Secondary 
to this, we explored between- and within-group differences to generate parameters 
for designing a full trial. 
Methods 
Participants 
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This study was approved by Institutional and NHS Research Ethics Committees 
(14/EM/1228). The trial was registered on ClinicalTrials.gov (ID: NCT02596633). 
Participants did not receive any financial incentive for participation. 
We aimed to recruit 25-30 participants: to generate data enabling parameter-
estimation for designing a full trial (Julious, 2005). Participants were recruited 
through a neurology outpatient clinic at an acute National Health Service (NHS) 
hospital in Nottingham, UK, and through an advertisement placed in a regional MS 
Society (charity) publication. Participants were adults with MS, diagnosed at least 12 
months prior to trial-enrolment. Participants were screened for psychological distress 
using the Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983). 
They were eligible if they met ‘caseness’ criteria on the HADS (scoring >7 for 
anxiety/depression), which is recommended in MS populations (Honarmand & 
Feinstein, 2009). Completion of the screening measure occurred in-clinic for those 
recruited through the NHS-service and via postal-return for those recruited through 
the MS Society. Participants unable to read and write English, and those receiving 
other psychotherapy, were excluded. Informed consent was obtained.  
Assessment 
Basic demographic details, time since MS diagnosis, time since last relapse, most 
recent Expanded Disability Status Scale (EDSS; Kurtzke, 1983) score, and current 
medication were noted from clinical records. Participants also self-reported current 
medications and contacts with health services on a bespoke healthcare-utilisation 
questionnaire. This is not a validated questionnaire but based on the resources 
available in the Database of Instruments for Resource Use Measurement (dirum.org; 
Ridyard & Hughes, 2012), which includes the number and types of primary and 
secondary care NHS resources used, and changes to employment status. 
Baseline assessments were administered to all participants pre-randomisation, and 
these assessments were repeated at follow-up, 12 weeks post-randomisation. Co-
primary outcome measures were the Generalised Anxiety Disorder 7-item (GAD-7) 
scale (Spitzer, Kroenke, Williams, & Löwe, 2006) and the Patient Health 
Questionnaire-9 (PHQ-9; Kroenke, Spitzer, & Williams), which captured anxiety and 
depression, respectively. Secondary outcomes were the Multiple Sclerosis Impact 
Scale (MSIS-29; Hobart, Lamping, Fitzpatrick, Riazi, & Thompson, 2001) which splits 
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into physical and psychological sub-scales (Ramp, Khan, Misajon, & Pallant, 2009). 
The EQ-5D-5L (Herdman et al., 2011) was administered to assess QoL. The 
Acceptance and Action Questionnaire (AAQ-II; Bond et al., 2011) was included as a 
process measure, to gauge variability in ACT-targeted processes of experiential 
avoidance and psychological inflexibility. Measures were administered securely 
online using www.esurv.org; except the EQ-5D-5L, which was administered and 
collected via post. 
Design 
The study was a pilot RCT – as defined by Eldridge et al. (2016). Participants were 
randomly allocated to intervention or control (1:1 ratio). The randomisation sequence 
was computer-generated by one researcher (NM), concealed from other 
researchers, and entered into a standalone web-based system (Cunningham, 2006). 
The recruiting researcher (BP) used this system to request individual time-stamped 
allocations at the point of consent, before informing the participant of their allocation.  
Feasibility and acceptability feedback was obtained via telephone-interviews, 
conducted by an independent researcher with a sub-sample of participants, 12-
weeks post-randomisation. We followed guidance for maximising the impact of 
qualitative methods within a pilot trial (O’Cathain et al., 2015) and used maximum 
variation purposive sampling to select five participants from each arm to capture a 
diverse range of perspectives within our sample, sufficient to provide elaborative 
nuance to this primarily quantitative design. 
Intervention 
The intervention arm consisted of TAU plus the self-help book “Get out of your mind 
and into your life” (Hayes, 2005) – with guidance on which chapters to read each 
week. This coincided with eight weekly support-calls, theoretically orientated to the 
ACT model, from a trainee clinical psychologist (BP), who supported participants in 
understanding the text and engaging with the model. BP received supervision from 
an experienced ACT practitioner-researcher (NM). The book covers all components 
of the ACT model and prompts self-application through multiple semi-structured 
exercises per chapter – enabling the reader to tailor material to their own 
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idiosyncratic needs. Participants in this arm received no other psychological 
therapies.  
The control arm consisted solely of TAU, conforming to UK National Institute for 
Health and Care Excellence guidance for MS symptoms (NICE, 2014), which 
typically involves referral to psychological services for intervention or medication for 
mood problems, although none in the TAU group accessed any psychological 
therapy. 
Analysis 
To assess feasibility and acceptability, framework analysis (Gale, Heath, Cameron, 
Rashid, & Redwood, 2013) of interview-data was undertaken by BP. Pre-defined 
codes about feasibility and acceptability of the study and intervention were assigned 
to interview-transcripts, then codes were amalgamated into a framework.  
Healthcare-utilisation was explored between groups using independent t-tests. Self-
report medication was cross-referenced against medication recorded in clinical 
notes. EQ-5D-5L scores were norm-converted using UK EQ-5D-5L value-sets. 
Independent t-tests were conducted to explore baseline differences between 
intervention completers vs. non-completers. 
RCT analysis used an intention-to-treat approach. Independent variables of ‘group 
allocation’ and ‘time point’ were entered into linear mixed models to explore 
interactions of intervention and time. This method provides unbiased estimates in the 
presence of missing data, enabling us to use all observed data and include 
participants who did not return data at all timepoints, so avoiding the need for (and 
potential biases of) methods of imputation. Given the feasibility-nature of the study, p 
values were not adjusted for multiple comparisons: consistent with recommendations 
for pilot and feasibility trials (Moore, Carter, Nietert, & Stewart, 2011) we sought to 
explore potential efficacy (to be tested subsequently in larger trials). To produce 
standardised estimates of effect for the linear mixed models, we applied Cohen's d 
calculation to the relevant data for estimated marginal means and their pooled 
standard deviation (Hedges, 2007); we additionally computed 95% confidence 
intervals around point-estimates of effect-size.  
7 
 
Sample-size estimates for a full trial were computed using the standard deviations of 
the GAD-7 and PHQ-9 at 12-weeks post-randomisation and published clinically 
significant change (CSC) values. 
Results 
Sample 
Two participants responded to the advertisement in the MS Society publication. 
From the outpatient clinic, consultants referred 33 patients, 25 of whom consented, 
to make up 27 enrolled participants. Demographic and baseline clinical 
characteristics of the sample are shown in Tables 1 and 2.  
Feasibility 
To summarise data from interview respondents (n=10) we refer to the number of 
participants endorsing particular codes using the terms “majority”, “some” and 
“minority”, meaning more than 75%, 50-75%, and under 50% (respectively) of all 
participants who referenced a given code.  
Recruitment  
The majority of interviewed participants found the pathway to recruitment appropriate 
and the recruitment process straightforward. A minority thought their neurologist 
using their appointment to discuss the trial was inappropriate. The majority thought 
the information provided by the recruiter (BP) was clear. A minority wanted more 
information about the commitment and work required from participants. 
Randomisation 
Whilst all interviewed participants agreed that randomisation was a fair way to 
allocate people to intervention or control, some participants reported they did not 
fully understand minutiae of the process – suggesting that provision of information 
about randomisation could be enhanced, to ensure that individuals are making 
suitably informed decisions about participation.   
Measures 
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At follow-up, 25 of 27 participants (93%) completed online-questionnaires, and 24 
participants (89%) completed postal-questionnaires (EQ-5D-5L only). On average, 
online-questionnaires took 14 minutes to complete (SD=9). 
The majority of interviewees found the questionnaire-items clear, easy and quick to 
complete, and appropriate for the study. Some participants reported wanting to add 
text to clarify their responses, because response-options did not adequately capture 
their experiences.  
Self-reported healthcare-utilisation  
At follow-up, 25 of 27 participants (93%) reported their frequency of MS-related 
service contacts over the preceding three months. In the intervention group, the 
mean number of contacts was 10.8 (SD=6.6) versus 7.4 (SD=6.2) in the control 
group, which was not a statistically significant difference (p=0.2) but represented a 
moderate effect-size (d=0.53). Across 23 participants’ self-reporting medication use, 
there were 45 instances where clinical notes described a medication a participant 
had not listed – and 20 instances where participants self-reported a drug that was 
unlisted in clinical notes.  
Attrition 
Overall, 9 of 27 (33%) participants dropped out of the study. All nine were 
participants randomised to receive the intervention (within-group attrition of 64%). Of 
non-completers, six did not start the book and three dropped out after reading the 
first few chapters and receiving one support-call. Table 3 summarises reasons for 
non-completion.  
Baseline comparisons of completers versus non-completers revealed that non-
completers scored higher on the MSIS-physical and -psychological subscales and 
the AAQ-II at baseline (Table 4). 
Support-calls 
Of the five participants who completed the self-help book: three received the eight, 
scheduled support-calls, and completed the book within the expected seven weeks. 
Two received an extra phone-call, due to not completing chapters within the allotted 
time-period (one took 10 weeks to complete the book and the other took 12 weeks). 
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The average support-call length was 14 minutes (SD=6). Intervention participants 
rescheduled the timing of their support-calls on 8 of 42 occasions (19%); and there 
was one occasion where a scheduled call was missed. 
The majority of participants agreed that support-calls were helpful and appropriate in 
length, and that the researcher was supportive. However, they felt that either less 
text to read each week, or calls spaced further apart would have been a better pace 
for the intervention.  
Self-help text 
The majority of interviewed participants found the language used in the self-help text 
understandable, although a few found it too complex. The majority thought that the 
language was “Americanised”, and a considerable amount of re-reading was 
required. 
Regarding helpfulness of specific book-elements, there was variability across the 
sample. For example, one participant found the ‘Values’ chapter most helpful; one 
found the ‘Mindfulness’ chapter most helpful, and one found it unhelpful. The 
majority of interviewed participants thought that other people with MS would find the 
book and the phone-support helpful.  
Effectiveness 
As shown in Table 5, the intent-to-treat2 linear mixed model3 analyses found a 
significant interaction effect for time and allocation on the GAD-7 in favour of the 
intervention at follow-up (F=10.34, p=0.004). No statistically-significant comparisons 
were identified for depression, QoL, or MSIS outcomes.  
Effect-sizes at follow-up, with 95% confidence intervals (CI), are displayed in Table 
5. A large and significant effect-size (d=0.84, 95% CI=0.02-1.66) was found in favour 
of the intervention on one of the co-primary outcomes measure of GAD-7 at follow-
up, but not the other (PHQ-9 [d=0.2, 95% CI=-0.59-0.99]). The strengths of the 
                                            
2
 Per protocol analysis results were similar in that a significant interaction of time and group allocation 
for the GAD-7 (anxiety) was found (F=8.7, p=0.011) with a large effect size (d=2.054, 95% CI=0.8-
3.3). 
3
 Mixed ANOVAs of all dependent variables were also conducted. A similar trend of results was found 
to the linear mixed models in that there was a significant interaction of time and group allocation for 
the GAD-7 (anxiety) and no other significant effects. 
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effect-estimates vary across measures; however, all estimates were positive and 
favoured intervention.  
Sample Size Estimation 
In a full trial, a total of 34 participants (i.e., 17 per arm) would be required to have a 
90% chance of detecting, as significant at the 5% level, a clinically significant 
decrease of five points on the GAD-7. With the same criteria, 76 participants (38 per 
arm) would be required to detect clinically significant decrease on the PHQ-9. These 
figures would need to be higher to account for attrition. 
Discussion 
This is the first study to evaluate the feasibility of conducting a telephone-supported 
ACT bibliotherapy for people with MS and psychological distress. Regarding the 
primary aim, whilst some aspects of trial design appeared viable (e.g., recruitment, 
randomisation, and outcome measurement) the high level of attrition in the 
intervention arm identified problems with the piloted approach to implementing 
telephone-supported ACT bibliotherapy. However, preliminary effect-estimates were 
promising, and warrant further testing.  
Trial procedures 
Recruitment was straightforward, and the required number of participants was 
recruited within three months. Some additional information regarding the 
commitments required to participate is needed. Participants did not object to being 
randomised, but additional information about the rationale and need for 
randomisation may improve understanding of this process. With good completion of 
online- and postal-questionnaires (>89%), most participants found the questionnaires 
easy to understand and complete. We attempted to collect healthcare-utilisation 
information in a non-validated self-report questionnaire. However, when compared to 
clinical records, there were marked discrepancies in both directions, with no 
consistent pattern. Both sources of information may be limited (Byford et al., 2007). 
On balance, in a future trial, we recommend collecting this information from patients, 
but by supplementing data collection with a telephone support from a researcher 
(Heinrich et al., 2011). Designing a validated healthcare utilisation measure may also 
be prudent.  
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Attrition 
Of most concern was the attrition rate. All the participants who dropped out from the 
study (33%) were from the intervention group. The mean attrition rate from a meta-
analysis of telephone-administered psychotherapy for depression was 7.6% (95% 
CI=4.23–10.90), across all studies (Mohr, Vella, Hart, Heckman, & Simon, 2008). 
Methodological differences notwithstanding, the level of attrition from the intervention 
group in our study therefore clearly suggests problems that participants had in 
engaging with the intervention. There were, however, a mixture of external factors 
and trial-related factors influencing participant drop-out. Most participants dropped 
out due to illness-related factors (e.g., episodes of worsening in clinical symptoms) 
or not being able to commit to the programme, and some dropped out as they found 
the self-help text too generic for their diagnosis of MS. 
Participants who dropped out tended to have higher baseline rates of MS-related 
physical and psychological distress compared to intervention-completers – 
suggesting that those who could benefit most from psychological intervention may be 
those most likely to disengage. Engagement with psychotherapy requires effort and 
concentration, and problem confrontation may initially increase distress and 
established avoidance responses (Bystedt, Rozental, Andersson, Boettcher, & 
Carlbring, 2014). People with higher rates of physical and psychological distress 
were potentially unable to tolerate and/or engage with the intervention, because of 
their illness-related distress or because of MS-related cognitive decline. 
Non-completers also had significantly higher baseline scores on the AAQ-II than 
completers. Therefore, ACT-based interventions may be less acceptable to people 
with high rates of experiential-avoidance, the very process that ACT attempts to 
reduce. People with lower rates of experiential-avoidance may find that the ACT 
model is more consistent with their pre-existing coping styles, facilitating 
engagement and building on established skills. For those higher in experiential 
avoidance, it may be important to provide more intensive therapist input at an early 
stage: supporting acculturation to an approach that markedly differs from established 
coping responses. Incorporation of more comprehensive measures of psychological 
flexibility (e.g., Francis, Dawson, & Golijani-Moghaddam, 2016) could enable greater 
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insight into whether/how differential functioning in ACT-targeted processes 
influences treatment engagement. 
Those who were able to engage with the self-help text (persisting beyond the early 
chapters) found the content to be beneficial and perceived that others with MS could 
benefit from it. However, interview feedback and completion-time data suggested 
that pacing should be revisited: allowing more time and flexibility to complete the 
materials (in the context of illness-related burden). The telephone support 
component was well-received: most calls were made as scheduled, and call 
durations were brief, suggesting that this form of adjunctive support would be 
acceptable and feasible to provide within limited resources. Based on responses 
indicating that some of the UK participants found (1) the language to be 
'Americanised' and overly complex/academic, and (2) the content to be sometimes 
difficult to relate to their (e.g., MS-specific) experiences, we would recommend the 
following adaptations: (1) UK-regionalisation and simplification of language and (2) 
either (i) additional guidance and support to self-apply the generic self-help materials 
(particularly early on; e.g., through an initial orientation meeting to set expectations 
and clarify relevance) or (ii) revision of the text to include more relatable (e.g., MS-
specific) examples. Any revisions should be made with iterative feedback from 
individuals with relevant lived experience, and with checks for fidelity to the core 
components of the ACT model (to ensure, for example, that changes to the form of 
language do not disrupt intended functions). 
Effectiveness 
A lack of power, multiple comparisons and large attrition rate make the detection of 
significant differences unlikely, yet a significant large effect was found for anxiety in 
favour of the intervention group at follow-up in intention-to-treat analysis. Ostensibly, 
this suggests initial evidence for the ‘success’ of the intervention and the strong 
effect of the intervention-completers in the analysis. Our study is the first to 
demonstrate a substantive effect of ACT on anxiety in people with MS, given non-
significant and small effect-magnitudes for this outcome in previous MS-specific ACT 
studies (Nordin & Rosman, 2011; Pakenham et al., 2017). Notably, our observed 
effect-size is similar to the pooled-estimate from a meta-analytic review of ACT on 
anxiety (0.84; Vøllestad, Nielsen, & Nielsen, 2012). 
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Less impact was evident on measures of depression. There were higher levels of 
anxiety than depression in this sample; whereas most research reports the reverse 
(Korostil & Feinstein, 2007; Mohr & Cox, 2001). Participants may have focally used 
the intervention to manage their primary presenting concern (anxiety).  
The high attrition-rate has limited the confidence with which we can estimate 
parameters for a full trial. However, the mixed-methods design of this pilot-trial was a 
strength; enabling more detailed exploration of practical issues and reason for 
withdrawal, with implications for improving participant retention in future studies.  
Conclusions 
Overall, we found that the current intervention design was not feasible for trialling 
telephone-supported ACT bibliotherapy for people with MS and psychological 
distress. Preliminary evidence indicates that the intervention may be effective in 
reducing anxiety, but high attrition suggests that the treatment cannot be evaluated 
on a larger scale without further user-testing and refinement. Such a process could 
be usefully informed by User-Centred Design principles and practices (Lyon & 
Koerner, 2016), and might include cognitive interviewing with prospective users 
(persons with MS) focussed on intervention content, format, and ease of 
understanding (Willis, 2015) with a view to maximising the acceptability of (and 
potential engagement with) the self-help materials. 
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Table 1. Baseline demographic characteristics of the control and intervention groups. 
 
TAU group   Intervention group p value 
 
(n=13) 
 
(n=14) 
 Characteristic  Mean (SD)  Mean (SD)  
Age, years, mean (SD) 45.8 (8.8) 
 
46 (12.4) 0.984a 
Male/Female 0/13 
 
3/11 0.22b 
Diagnosis, n (%) 
   
0.61c 
  Relapsing Remitting 10 (77%) 
 
9 (64%) 
   Primary Progressive 2 (15%) 
 
2 (14%) 
   Secondary Progressive 1 (8%) 
 
3 (21%) 
 Years since MS diagnosis (SD) 6.2 (4.7) 
 
9.7 (7.5) 0.16a 
Years since last relapse (SD) 2.5 (1.9) 
 
2.2 (3.9) 0.83a 
Marital Status 
   
0.152c 
  Single 3 
 
2 
   Married/Civil Partnership 7 
 
12 
   Divorced/Dissolved Partnership 2 
 
0 
   Widowed 1 
 
0 
 Employment Status 
   
0.746c 
  Full Time 3 
 
2 
   Part Time 3 
 
3 
   Unpaid Work 0 
 
1 
   Not Employed 6 
 
5 
   Retired 1 
 
2 
   In Education 0  1  
a=Independent t-test, b=Fisher's exact test, c=Pearson's chi squared. 
Table 2. Baseline clinical characteristics of the control and intervention groups. 
Characteristic  TAU   Intervention group p value 
 
(n=13) 
 
(n=14) 
  Mean (SD)  Mean (SD)  
HADS 18.5 (5.5) 
 
20.8 (4.8) 0.24a 
EDSS 4.9 (2) 
 
5.4 (1.6) 0.51a 
GAD-7 16.8 (4.8) 
 
18.3 (5) 0.45a 
PHQ-9 21.2 (5.9) 
 
22.1 (7.1) 0.72a 
MSIS-Physical 63.8 (14.3) 
 
60.6 (20.2) 0.63a 
MSIS-Psych 28.7 (7.8) 
 
29.9 (8.9) 0.7a 
EQ-5D-5L 0.356 (0.253) 
 
0.408 (0.292) 0.62a 
AAQ-II 23.8 (12.9)  27.4 (9.5) 0.41a 
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HADS: Hospital Anxiety and Depression Scale, EDSS: Expanded Disability Status Scale, EQ-5D: 
Quality of Life Measure, GAD: Generalised Anxiety Disorder scale, PHQ: Patient Health 
Questionnaire, MSIS-Physical: Multiple Sclerosis Impact Scale - Physical health subscale, MSIS-
Psych: Multiple Sclerosis Impact Scale - Psychological subscale, AAQ-II: Acceptance and Action 
Questionnaire, a: Independent t-test. 
 
Table 3. Completers and non-completers in the intervention group.  
  Intervention group (n=14) 
Completed Intervention 5 (36%) 
Non-completers: 9 (64%) 
   Too busy 4 (29%) 
   Lost to follow-up 2 (14%) 
   Book described as inappropriate 2 (14%) 
   Too unwell 1 (7%) 
 
Table 4. Baseline characteristics of intervention completers and non-completers. 
 
Group 
  
 
Completers (n=5)   Non-completers (n=9) 
  Characteristic/Measure Mean (SD)   Mean (SD)  p value 
Age, (years) 51.8 (6) 
 
42.7 (14) 
 
0.2a 
Years since MS diagnosis 11.2 (7.8) 
 
8.9 (7.7) 
 
0.62a 
Years since last relapse 2.2 (2.6) 
 
2.3 (4.4) 
 
0.96a 
Diagnosis, n (%) 
    
0.9c 
  Relapsing Remitting 3 
 
6 
    Primary Progressive 1 
 
1 
    Secondary Progressive 1 
 
2 
  HADS 19.4 (4.6) 
 
21.7 (5) 
 
0.42a 
EDSS** 4.5 (2) 
 
5.8 (1.1) 
 
0.3a 
GAD-7 15.2 (2.9) 
 
20 (5) 
 
0.85a 
PHQ-9 18.8 (6.9) 
 
24 (6.9) 
 
0.2a 
MSIS-Physical 45.2 (15) 
 
69 17.9) 
 
0.027a* 
MSIS-Psych 22.6 (7.6) 
 
34 (6.9) 
 
0.014a* 
EQ-5D-5L 0.49 (0.18) 
 
0.36 (0.33) 
 
0.44a 
AAQ-II 19.6 (6.9) 
 
31.8 (7.9) 
 
0.014a* 
Service use (no of contacts) 8.4 (5)  12.2 (7.2)  0.28a 
a=Student's t test, b=Fisher's exact test, c=Pearson's chi squared. 
**completers: n=5; non-completers: n=8. *= significant at p=0.05 
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Table 5. Baseline and follow-up means between and within groups, results of linear model analyses of 
interaction effects of allocation and time, and effect sizes of intervention vs TAU at follow-up. 
 
Time 
    
 
Pre-randomisation 
  
Follow-up 
 
     
 
TAU 
(n=13) 
 
Interventio
n (n=14) 
  
TAU 
(n=12) 
 
Interventio
n (n=13) 
 
F (p 
value) 
Effect size 
(95% CIs) 
at follow-
up 
Measur
e 
Mean 
(SD)   Mean (SD)     
Mean 
(SD)   Mean (SD) 
 
Interactio
n effect 
GAD-7 
16.8 
(4.8) 
 
18.3 (5) 
 
GAD-7 
16.8 
(4.6) 
 
12.7 (5.2) 
 
10.34 
(0.004) 
0.84 
(0.02-
1.66) 
PHQ-9 
21.2 
(5.9) 
 
22.1 (7.1) 
 
PHQ-9 
19.6 
(6.3) 
 
18.4 (7.5) 
 
0.74 
(0.39) 
0.2 (-0.59-
0.99) 
MSIS-
Physical 
63.8 
(14.3) 
 
60.6 (20.2) 
 
MSIS-
Physical 
60.6 
(16.7) 
 
57.5 (21.7) 
 
0.016 
(0.9) 
0.14 (-
0.65-0.92) 
MSIS-
Psych 
28.7 
(7.8) 
 
29.9 (8.9) 
 
MSIS-
Psych 
28.1 
(9.3) 
 
24.5 (10.6) 
 
3.82 
(0.063) 
0.46 
(0.34-
1.25) 
EQ-5D-
5L 
0.36 
(0.25) 
 
0.41 (0.29) 
 
EQ-5D-
5L* 
0.44 
(0.2) 
 
0.45 (0.22) 
 
0.099 
(0.756) 
0.11 (-
0.71-0.93) 
AAQ-II 
23.8 
(12.9)   27.4 (9.5)   AAQ-II** 
23.4 
(12.5)   20.9 (13.2) 
 
2.868 
(0.105) 
0.23 (-
0.58-1.03) 
*: n for TAU = 11, n for Intervention = 12, **: n for TAU = 11, n for Intervention = 13. 
HADS: Hospital Anxiety and Depression Scale, EDSS: The Expanded Disability Status Scale, EQ-5D-5L: Quality of Life 
Measure, GAD: Generalised Anxiety Disorder scale, PHQ: Patient Health Questionnaire, MSIS-Physical: Multiple 
Sclerosis Impact Scale - Physical health subscale, MSIS-Psych: Multiple Sclerosis Impact Scale - Psychological 
subscale, AAQ-II: Acceptance and Action Questionnaire. 
20 
 
 
Fig. 1: Flow of participants through the study. 
Highlights 
 Preliminary evidence that the intervention can reduce anxiety in those with MS 
 Low adherence and high attrition suggest the current trial-design lacks feasibility 
 Further user-testing and design adaptation is warranted, given preliminary evidence 
 
